NCT01822730View on ClinicalTrials.gov

A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

May 31, 2014

Conditions
Methamphetamine Dependence
Interventions
DRUG

paliperidone

Paliperidone group,6mg/pill,6mg-12mg/day non-forced titration method,last 2-4weeks

DRUG

Risperidone

Risperidone group,1mg/pill,2mg-6mg/day non-forced titration method,last 2-4weeks

Trial Locations (1)

410011

The Second Xiangya Hospital of Central University, Changsha

All Listed Sponsors
lead

Wei Hao

OTHER

NCT01822730 - A Comparison of Paliperidone and Risperidone for Treatment of Patirnts With Methamphetamine-Associated Psychosis | Biotech Hunter | Biotech Hunter